Search research articles
Contact Us
Filters
Showing results (1-10 of 44) with videos related to
Page
of 5
Sort By:
Vaccines
|
December 23, 2022
Harnessing NK Cells to Control Metastasis
Xuewen Deng, Hiroshi Terunuma
Immunity & Ageing : I & A
|
June 26, 2024
Adoptive NK cell therapy: a potential revolutionary approach in longevity therapeutics
Xuewen Deng, Hiroshi Terunuma
Biomedicines
|
June 2, 2021
Immunosurveillance of Cancer and Viral Infections with Regard to Alterations of Human NK Cells Originating from Lifestyle and Aging
Xuewen Deng, Hiroshi Terunuma, Mie Nieda
Biomedicines
|
May 28, 2022
Exploring the Utility of NK Cells in COVID-19
Xuewen Deng, Hiroshi Terunuma, Mie Nieda
International Journal of Stem Cells
|
December 5, 2014
Combining autologous peripheral blood mononuclear cells with fibroblast growth factor therapy along with stringent infection control leading to successful limb salvage in diabetic patient with chronic renal failure and severe toe gangrene
Hiroshi Osawa, Kouan Orii, Hiroshi Terunuma, et al.
Regenerative Therapy
|
June 28, 2019
Experience of contamination during autologous cell manufacturing in cell processing facility under the Japanese Medical Practitioners Act and the Medical Care Act
Manabu Mizutani, Hazuki Samejima, Hiroshi Terunuma, et al.
Journal of Stem Cells & Regenerative Medicine
|
June 27, 2019
Comparative transcriptomic analysis of human mesenchymal stem cells derived from dental pulp and adipose tissues
Atsushi Terunuma, Keisuke Ashiba, Tsubasa Takane, et al.
International Reviews of Immunology
|
April 26, 2008
Potential role of NK cells in the induction of immune responses: implications for NK cell-based immunotherapy for cancers and viral infections
Hiroshi Terunuma, Xuewen Deng, Zahidunnabi Dewan, et al.
International Immunopharmacology
|
October 16, 2012
Synergistic cytotoxicity of ex vivo expanded natural killer cells in combination with monoclonal antibody drugs against cancer cells
Xuewen Deng, Hiroshi Terunuma, Mie Nieda, et al.
International Immunopharmacology
|
August 19, 2014
Ex vivo-expanded natural killer cells kill cancer cells more effectively than ex vivo-expanded γδ T cells or αβ T cells
Xuewen Deng, Hiroshi Terunuma, Atsushi Terunuma, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 44) with videos related to
Sort By:
Page
of 5
Vaccines
|
December 23, 2022
Harnessing NK Cells to Control Metastasis
Xuewen Deng, Hiroshi Terunuma
Immunity & Ageing : I & A
|
June 26, 2024
Adoptive NK cell therapy: a potential revolutionary approach in longevity therapeutics
Xuewen Deng, Hiroshi Terunuma
Biomedicines
|
June 2, 2021
Immunosurveillance of Cancer and Viral Infections with Regard to Alterations of Human NK Cells Originating from Lifestyle and Aging
Xuewen Deng, Hiroshi Terunuma, Mie Nieda
Biomedicines
|
May 28, 2022
Exploring the Utility of NK Cells in COVID-19
Xuewen Deng, Hiroshi Terunuma, Mie Nieda
International Journal of Stem Cells
|
December 5, 2014
Combining autologous peripheral blood mononuclear cells with fibroblast growth factor therapy along with stringent infection control leading to successful limb salvage in diabetic patient with chronic renal failure and severe toe gangrene
Hiroshi Osawa, Kouan Orii, Hiroshi Terunuma, et al.
Regenerative Therapy
|
June 28, 2019
Experience of contamination during autologous cell manufacturing in cell processing facility under the Japanese Medical Practitioners Act and the Medical Care Act
Manabu Mizutani, Hazuki Samejima, Hiroshi Terunuma, et al.
Journal of Stem Cells & Regenerative Medicine
|
June 27, 2019
Comparative transcriptomic analysis of human mesenchymal stem cells derived from dental pulp and adipose tissues
Atsushi Terunuma, Keisuke Ashiba, Tsubasa Takane, et al.
International Reviews of Immunology
|
April 26, 2008
Potential role of NK cells in the induction of immune responses: implications for NK cell-based immunotherapy for cancers and viral infections
Hiroshi Terunuma, Xuewen Deng, Zahidunnabi Dewan, et al.
International Immunopharmacology
|
October 16, 2012
Synergistic cytotoxicity of ex vivo expanded natural killer cells in combination with monoclonal antibody drugs against cancer cells
Xuewen Deng, Hiroshi Terunuma, Mie Nieda, et al.
International Immunopharmacology
|
August 19, 2014
Ex vivo-expanded natural killer cells kill cancer cells more effectively than ex vivo-expanded γδ T cells or αβ T cells
Xuewen Deng, Hiroshi Terunuma, Atsushi Terunuma, et al.
Page
of 5